Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker?
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker?
Authors
Keywords
-
Journal
Frontiers in Neurology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-03-26
DOI
10.3389/fneur.2019.00280
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cognitive impairment in early stages of multiple sclerosis is associated with high cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain
- (2018) E. Quintana et al. EUROPEAN JOURNAL OF NEUROLOGY
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
- (2018) Alan J Thompson et al. LANCET NEUROLOGY
- Assessing treatment outcomes in multiple sclerosis trials and in the clinical setting
- (2018) Carmen Tur et al. Nature Reviews Neurology
- Prognostic value of cerebrospinal fluid neurofilament light chain and chitinase-3-like-1 in newly diagnosed patients with multiple sclerosis
- (2018) Finn Sellebjerg et al. Multiple Sclerosis Journal
- Can we trust self-reported walking distance when determining EDSS scores in patients with multiple sclerosis? The Danish MS hospitals rehabilitation study
- (2018) Anders Guldhammer Skjerbæk et al. Multiple Sclerosis Journal
- Serum GFAP as a biomarker for disease severity in multiple sclerosis
- (2018) A. Abdelhak et al. Scientific Reports
- Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity
- (2018) Heidi Högel et al. Multiple Sclerosis Journal
- YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer’s disease and other tauopathies
- (2017) Marta Querol-Vilaseca et al. Journal of Neuroinflammation
- Increases of Plasma Levels of Glial Fibrillary Acidic Protein, Tau, and Amyloid β up to 90 Days after Traumatic Brain Injury
- (2017) Tanya Bogoslovsky et al. JOURNAL OF NEUROTRAUMA
- Age Related Multiple Sclerosis Severity Score: Disability ranked by age
- (2017) Ali Manouchehrinia et al. Multiple Sclerosis Journal
- Neurotoxic reactive astrocytes are induced by activated microglia
- (2017) Shane A. Liddelow et al. NATURE
- GFAP in early multiple sclerosis: A biomarker for inflammation
- (2017) Rebecca Kassubek et al. NEUROSCIENCE LETTERS
- Age Related Multiple Sclerosis Severity Score: Disability ranked by age
- (2017) Ali Manouchehrinia et al. Multiple Sclerosis Journal
- Primary Progressive Multiple Sclerosis: Putting Together the Puzzle
- (2017) Ahmed Abdelhak et al. Frontiers in Neurology
- sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers
- (2016) Marc Suárez‐Calvet et al. EMBO Molecular Medicine
- YKL-40 is a CSF biomarker of intrathecal inflammation in secondary progressive multiple sclerosis
- (2016) Joachim Burman et al. JOURNAL OF NEUROIMMUNOLOGY
- Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis
- (2016) M.Alba Mañé-Martínez et al. JOURNAL OF NEUROIMMUNOLOGY
- Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone
- (2016) Annika Öhrfelt et al. Multiple Sclerosis Journal
- Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity
- (2016) Jens Kuhle et al. Multiple Sclerosis Journal
- Early changes in CSF sTREM2 in dominantly inherited Alzheimers disease occur after amyloid deposition and neuronal injury
- (2016) M. Suarez-Calvet et al. Science Translational Medicine
- Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone
- (2016) Annika Öhrfelt et al. Multiple Sclerosis Journal
- Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity
- (2016) Jens Kuhle et al. Multiple Sclerosis Journal
- Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes
- (2015) Ester Cantó et al. BRAIN
- Brain-Specific Cytoskeletal Damage Markers in Cerebrospinal Fluid: Is There a Common Pattern between Amyotrophic Lateral Sclerosis and Primary Progressive Multiple Sclerosis?
- (2015) Ahmed Abdelhak et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Biomarkers of Traumatic Injury Are Transported from Brain to Blood via the Glymphatic System
- (2015) B. A. Plog et al. JOURNAL OF NEUROSCIENCE
- Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives
- (2015) Daniel Ontaneda et al. LANCET NEUROLOGY
- Pathological mechanisms in progressive multiple sclerosis
- (2015) Don H Mahad et al. LANCET NEUROLOGY
- Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
- (2015) M Alba Mañé Martínez et al. Multiple Sclerosis Journal
- Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis
- (2015) G Hinsinger et al. Multiple Sclerosis Journal
- Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
- (2015) M Alba Mañé Martínez et al. Multiple Sclerosis Journal
- Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis
- (2015) G Hinsinger et al. Multiple Sclerosis Journal
- Mechanisms of white matter damage in multiple sclerosis
- (2014) Hans Lassmann GLIA
- Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation
- (2014) Lior Mayo et al. NATURE MEDICINE
- TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis
- (2014) G. Kleinberger et al. Science Translational Medicine
- Multiple sclerosis: Lessons from molecular neuropathology
- (2013) Hans Lassmann EXPERIMENTAL NEUROLOGY
- The innate immune system in demyelinating disease
- (2012) Lior Mayo et al. IMMUNOLOGICAL REVIEWS
- Progressive multiple sclerosis: pathology and pathogenesis
- (2012) Hans Lassmann et al. Nature Reviews Neurology
- Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis
- (2010) Manuel Comabella et al. BRAIN
- In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases
- (2010) Dafna Bonneh-Barkay et al. Journal of Neuroinflammation
- Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis
- (2010) M. Axelsson et al. JOURNAL OF NEUROLOGY
- Astrocytes: biology and pathology
- (2009) Michael V. Sofroniew et al. ACTA NEUROPATHOLOGICA
- Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: Effects of oligomeric and fibrillar amyloid-β
- (2009) Alessandro Michelucci et al. JOURNAL OF NEUROIMMUNOLOGY
- A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
- (2009) C. E. Teunissen et al. NEUROLOGY
- Proteome Profiling in Murine Models of Multiple Sclerosis: Identification of Stage Specific Markers and Culprits for Tissue Damage
- (2009) Ralf A. Linker et al. PLoS One
- Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation
- (2008) Laura Piccio et al. BRAIN
- Debris clearance by microglia: an essential link between degeneration and regeneration
- (2008) H. Neumann et al. BRAIN
- Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases
- (2008) Hayrettin Tumani et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started